The Private Sector Constituency

The Private Sector Constituency of the Roll Back Malaria Partnership (RBM) is broadly defined as the community of businesses with a recognized role or interest in malaria control. There are several key areas in which the private sector has been able to contribute to the RBM. The Global Health Initiative of the World Economic Forum helps coordinate this engagement in the RBM Partnership.

The private sector possesses a breadth of expertise and implementation skills – including delivering products and programmes in the developing world. These skills include innovation, production and distribution at global and country levels. Additionally, many enterprises within the private sector have global reach. Companies deliver products, communicate to diverse customers and provide a myriad of services to the most remote places. There are many examples of successful malaria control programmes implemented by companies in partnership with governments, particularly in Africa: They provide support, treatment and care to millions of employees and citizens that would otherwise not have access to curative services.

Second, the private sector has a particularly important role to play in ensuring the supply and efficient distribution of drugs, diagnostics and other interventions against malaria. In addition, a major objective of the Partnership is to develop “new tools” – novel effective drugs, diagnostics and vaccines to replace the decades-old existing tools to achieve better malaria control and eventual elimination.

Private sector involvement comes from a variety of industries that are relevant to the goals of the RBM Partnership, such as those companies with expertise in implementation of malaria programmes in affected countries (for example mining, energy, construction companies) or those with skills in development of related medical products. Consulting, media/communications, logistics and consumer goods companies have a broad range of skills and experiences that are pertinent to current issues in malaria such as advocacy, procurement and distribution. Finally, the private sector can bring the “business mindset” to the RBM Partnership, with its emphasis on good management practices and tangible results.

Structures of the Private Sector Constituency
Private Sector Constituency (PSC): A broad group that includes companies/businesses that are interested in malaria activities but may not necessarily have signed the Private Sector Constituency Conflict of Interest Policy (PSC COI).
View Private Sector Constituency Roll Back Malaria Partnership Conflict of Interest Policy

Private Sector Delegation (PSD): A subset of the PSC including; all those corporate representatives who have signed the PSC COI Policy. They may serve as formal representatives in RBM mechanisms and other functions of the RBM Partnership

Private Sector Representatives: A subset of the PSD including; the two official Board Members, their alternates and the focal point (FP) who have signed the PSC COI Policy.

The private sector is represented on the RBM Board by a Board and Alternate Member. The private sector is also active in the sub-regional networks.

Contact Information
For further information or interest in participating in the Private Sector Constituency activities and/or RBM Partnership Working Groups, please contact:
Tom Achoki, Project Manager, Global Health Initiative, World Economic Forum Tel.: +41 (0)22 869 1274, e-mail: Tom.Achoki@weforum.org.
Read Private Sector Constituency Newsletter First Edition, May 2009
Visit Private Sector Constituency SharePoint site (Password required).

	A-Z Textile Mills [Ungalimited Industrial Area, P.O.Box 945, Arusha]
	BASF
	Bayer
	ENI
	ExxonMobil
	GlaxoSmithKline
	H.D. Hudson Manufacturing Company
	Novartis
	Procter & Gamble
	Sanofi Aventis
	Sumitomo Chemical
	Syngenta
	Vestergaard Frandsen
	World Economic Forum